Candel Therapeutics, Inc. - Common Stock (CADL)
CUSIP: 137404109
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 73,330,024
- Total 13F shares
- 23,634,025
- Share change
- +963,513
- Total reported value
- $133,509,415
- Put/Call ratio
- 35%
- Price per share
- $5.65
- Number of holders
- 84
- Value change
- +$5,752,184
- Number of buys
- 46
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 137404109?
CUSIP 137404109 identifies CADL - Candel Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 137404109:
Top shareholders of CADL - Candel Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Estuardo Aguilar-Cordova |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,371,832
|
$52,549,421 | — | 21 Feb 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
15%
from 13D/G
|
8,233,385
|
$41,990,263 | — | 30 Sep 2025 | |
| Paul B. Manning |
13D/G
|
— |
7.9%
|
5,790,999
|
$29,997,375 | $0 | 16 Dec 2024 | |
| ACORN BIOVENTURES, L.P. |
13D/G
|
Anders Hove |
5.2%
|
2,580,517
|
$14,115,428 | $0 | 25 Jun 2025 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
3.5%
|
2,580,517
|
$13,160,637 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.2%
|
2,379,330
|
$12,134,582 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13D/G
|
— |
5%
|
2,455,108
|
$11,882,723 | -$2,550,075 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
2,007,112
|
$10,236,272 | — | 30 Sep 2025 | |
| Portolan Capital Management, LLC |
13F
|
Company |
1.9%
|
1,384,142
|
$7,059,124 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
928,197
|
$4,734,652 | — | 30 Sep 2025 | |
| Halter Ferguson Financial Inc. |
13F
|
Company |
0.95%
|
698,004
|
$3,559,821 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.94%
|
688,766
|
$3,512,707 | — | 30 Sep 2025 | |
| Christopher Martell |
3/4/5
|
Director |
—
mixed-class rows
|
561,103
mixed-class rows
|
$2,902,260 | — | 25 Jun 2025 | |
| Laura K. Aguilar |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,046,940
|
$2,742,246 | — | 06 May 2022 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.55%
|
405,837
|
$2,069,769 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
306,775
|
$1,564,553 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.34%
|
252,291
|
$1,286,684 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
223,821
|
$1,141,487 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.29%
|
209,662
|
$1,069,276 | — | 30 Sep 2025 | |
| Tanager Wealth Management LLP |
13F
|
Company |
0.27%
|
198,175
|
$1,010,693 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.19%
|
137,888
|
$703,229 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
136,670
|
$697,017 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
136,116
|
$694,192 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
121,004
|
$617,120 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.14%
|
103,847
|
$529,621 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
94,569
|
$482,300 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
94,071
|
$479,762 | — | 30 Sep 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.11%
|
82,221
|
$419,000 | — | 30 Sep 2025 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.11%
|
79,316
|
$404,512 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
75,941
|
$387,300 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.09%
|
69,110
|
$352,461 | — | 30 Sep 2025 | |
| Lido Advisors, LLC |
13F
|
Company |
0.08%
|
60,201
|
$307,025 | — | 30 Sep 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.08%
|
60,000
|
$306,000 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
59,595
|
$303,934 | — | 30 Sep 2025 | |
| HB Wealth Management, LLC |
13F
|
Company |
0.08%
|
58,345
|
$297,560 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
55,100
|
$281,010 | — | 30 Sep 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
54,047
|
$275,640 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
53,640
|
$273,556 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.07%
|
49,483
|
$252,363 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
47,643
|
$242,980 | — | 30 Sep 2025 | |
| MONETA GROUP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.06%
|
40,517
|
$206,637 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
36,021
|
$183,707 | — | 30 Sep 2025 | |
| Jason Amello |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
292,009
mixed-class rows
|
$181,808 | — | 28 Nov 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
30,962
|
$157,906 | — | 30 Sep 2025 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.04%
|
30,386
|
$155,000 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
26,659
|
$135,961 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
26,311
|
$134,186 | — | 30 Sep 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
26,278
|
$134,018 | — | 30 Sep 2025 | |
| Stratos Wealth Advisors, LLC |
13F
|
Company |
0.03%
|
23,000
|
$117,300 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.03%
|
22,164
|
$113,036 | — | 30 Sep 2025 |
Institutional Holders of Candel Therapeutics, Inc. - Common Stock (CADL) as of Q4 2025
As of 31 Dec 2025,
Candel Therapeutics, Inc. - Common Stock (CADL) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,634,025 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., ACORN CAPITAL ADVISORS, LLC, VANGUARD GROUP INC, Portolan Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Halter Ferguson Financial Inc., Sands Capital Alternatives, LLC, and NORTHERN TRUST CORP.
This page lists
84
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
81
Q4 2025 holders
84
Holder diff
3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.